Annual Accounts Payable
$8.29 M
-$541.00 K-6.13%
31 December 2021
Summary:
Aerie Pharmaceuticals annual accounts payable is currently $8.29 million, with the most recent change of -$541.00 thousand (-6.13%) on 31 December 2021. During the last 3 years, it has fallen by -$541.00 thousand (-6.13%).AERI Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$9.06 M
-$217.00 K-2.34%
30 September 2022
Summary:
Aerie Pharmaceuticals quarterly accounts payable is currently $9.06 million, with the most recent change of -$217.00 thousand (-2.34%) on 30 September 2022.AERI Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -6.1% | +12.2% |
| 5 y5 years | -33.2% | -21.1% |
AERI Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -35.1% | -29.0% |
Aerie Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $9.06 M(-2.3%) |
| June 2022 | - | $9.28 M(+17.8%) |
| Mar 2022 | - | $7.88 M(-4.9%) |
| Dec 2021 | $8.29 M(-6.1%) | $8.29 M(+2.6%) |
| Sept 2021 | - | $8.08 M(+8.6%) |
| June 2021 | - | $7.44 M(+14.1%) |
| Mar 2021 | - | $6.52 M(-26.1%) |
| Dec 2020 | $8.83 M(-30.9%) | $8.83 M(+94.6%) |
| Sept 2020 | - | $4.54 M(-31.9%) |
| June 2020 | - | $6.66 M(-27.7%) |
| Mar 2020 | - | $9.21 M(-27.9%) |
| Dec 2019 | $12.77 M(+3.0%) | $12.77 M(+11.2%) |
| Sept 2019 | - | $11.48 M(+26.2%) |
| June 2019 | - | $9.10 M(-18.2%) |
| Mar 2019 | - | $11.12 M(-10.3%) |
| Dec 2018 | $12.40 M(+98.6%) | $12.40 M(+75.5%) |
| Sept 2018 | - | $7.07 M(-19.3%) |
| June 2018 | - | $8.76 M(+44.4%) |
| Mar 2018 | - | $6.07 M(-2.9%) |
| Dec 2017 | $6.25 M | $6.25 M(+71.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2017 | - | $3.65 M(+66.4%) |
| June 2017 | - | $2.19 M(+12.1%) |
| Mar 2017 | - | $1.96 M(-65.1%) |
| Dec 2016 | $5.61 M(+244.4%) | $5.61 M(+164.6%) |
| Sept 2016 | - | $2.12 M(-6.6%) |
| June 2016 | - | $2.27 M(-39.0%) |
| Mar 2016 | - | $3.72 M(+128.5%) |
| Dec 2015 | $1.63 M(-21.2%) | $1.63 M(-19.4%) |
| Sept 2015 | - | $2.02 M(-2.4%) |
| June 2015 | - | $2.07 M(-34.8%) |
| Mar 2015 | - | $3.18 M(+53.8%) |
| Dec 2014 | $2.07 M(+43.4%) | $2.07 M(-32.0%) |
| Sept 2014 | - | $3.04 M(+106.5%) |
| June 2014 | - | $1.47 M(+18.1%) |
| Mar 2014 | - | $1.25 M(-13.6%) |
| Dec 2013 | $1.44 M(+728.7%) | $1.44 M(+28.1%) |
| Sept 2013 | - | $1.13 M(+130.7%) |
| June 2013 | - | $488.00 K(+180.5%) |
| Dec 2012 | $174.00 K(-23.0%) | $174.00 K |
| Dec 2011 | $226.00 K | - |
FAQ
- What is Aerie Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Aerie Pharmaceuticals?
What is Aerie Pharmaceuticals annual accounts payable?
The current annual accounts payable of AERI is $8.29 M
What is the all time high annual accounts payable for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high annual accounts payable is $12.77 M
What is Aerie Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of AERI is $9.06 M
What is the all time high quarterly accounts payable for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high quarterly accounts payable is $12.77 M